1. Adalimumab-related hypoglycaemia in patients with diabetes

   News item 22 October 2022 Pages: 1 - 1

2. Batch of hameln pharma's amiodarone recalled due to crystals

   News item 22 October 2022 Pages: 2 - 2

3. COVID-19 vaccine-related anaphylaxis and other allergic reactions

   News item 22 October 2022 Pages: 3 - 3

4. MHRA response to contaminated paediatric medicines in the Gambia

   News item 22 October 2022 Pages: 4 - 4

5. Sanofi recalls batches of Stemetil Syrup due to nitrosamines

   News item 22 October 2022 Pages: 5 - 5

6. Sertraline-related risk of microscopic colitis

   News item 22 October 2022 Pages: 6 - 6

7. AEs after COVID-19 vaccination in patients with epilepsy

   Clinical study 22 October 2022 Pages: 7 - 7

8. Anti-IL-17 agents increase risk of Candida infection in patients with psoriasis

   Clinical study 22 October 2022 Pages: 8 - 8

9. JAK inhibitors for atopic dermatitis have similar safety profiles

   Clinical study 22 October 2022 Pages: 9 - 9

10. Multiple sclerosis immunotherapies increase risk of COVID-19 mortality

    Clinical study 22 October 2022 Pages: 10 - 10

11. Network analysis for signal detection using EudraVigilance data

    Clinical study 22 October 2022 Pages: 11 - 11

12. Trimethoprim-sulfamethoxazole: risk of hospital encounter with hyperkalaemia in elderly

    Clinical study 22 October 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 22 October 2022 Pages: 13 - 13

14. Acetazolamide

    Case report 22 October 2022 Pages: 14 - 14

15. Acetazolamide/azd-1222

    Case report 22 October 2022 Pages: 15 - 15

16. Ad26.cov2-s/albumin-human

    Case report 22 October 2022 Pages: 16 - 16

17. Ad26.COV2-S/heparin

    Case report 22 October 2022 Pages: 17 - 17

18. Adalimumab

    Case report 22 October 2022 Pages: 18 - 18

19. Adalimumab

    Case report 22 October 2022 Pages: 19 - 19

20. Adalimumab/amphotericin-B

    Case report 22 October 2022 Pages: 20 - 20

21. Adefovir dipivoxil

    Case report 22 October 2022 Pages: 21 - 21

22. Adenosine

    Case report 22 October 2022 Pages: 22 - 22

23. Albumin-human/azathioprine

    Case report 22 October 2022 Pages: 23 - 23

24. Alectinib/crizotinib

    Case report 22 October 2022 Pages: 24 - 24

25. Alendronic-acid/alendronic-acid/colecalciferol

    Case report 22 October 2022 Pages: 25 - 25

26. Alfacalcidol/calcium-carbonate

    Case report 22 October 2022 Pages: 26 - 26

27. Allopurinol/antineoplastics

    Case report 22 October 2022 Pages: 27 - 27

28. Allopurinol/cefepime/oxcarbazepine

    Case report 22 October 2022 Pages: 28 - 28

29. Alprazolam/carbamazepine/flumazenil

    Case report 22 October 2022 Pages: 29 - 29

30. Alteplase

    Case report 22 October 2022 Pages: 30 - 30

31. Amikacin/linezolid

    Case report 22 October 2022 Pages: 31 - 31

32. Amiodarone

    Case report 22 October 2022 Pages: 32 - 32

33. Amiodarone

    Case report 22 October 2022 Pages: 33 - 33

34. Amiodarone

    Case report 22 October 2022 Pages: 34 - 34

35. Amiodarone/lidocaine

    Case report 22 October 2022 Pages: 35 - 35

36. Amoxicillin

    Case report 22 October 2022 Pages: 36 - 36

37. Amoxicillin/ibuprofen/paracetamol

    Case report 22 October 2022 Pages: 37 - 37

38. Amoxicillin/tranexamic acid

    Case report 22 October 2022 Pages: 38 - 38

39. Amphotericin-B

    Case report 22 October 2022 Pages: 39 - 39

40. Amphotericin-B-liposomal

    Case report 22 October 2022 Pages: 40 - 40

41. Amphotericin-B-liposomal/voriconazole

    Case report 22 October 2022 Pages: 41 - 41

42. Amphotericin-B/flucytosine/voriconazole

    Case report 22 October 2022 Pages: 42 - 42

43. Amyl nitrite abuse

    Case report 22 October 2022 Pages: 43 - 43

44. Anakinra

    Case report 22 October 2022 Pages: 44 - 44

45. Anakinra/dexamethasone

    Case report 22 October 2022 Pages: 45 - 45

46. Anakinra/tozinameran

    Case report 22 October 2022 Pages: 46 - 46

47. Anti-digoxin-polyclonal-antibody/digoxin

    Case report 22 October 2022 Pages: 47 - 47

48. Anti-inflammatories

    Case report 22 October 2022 Pages: 48 - 48

49. Antiasthmatics/umeclidinium

    Case report 22 October 2022 Pages: 49 - 49

50. Antibacterials/clindamycin

    Case report 22 October 2022 Pages: 50 - 50